6 recruiting, 4 completed, 1 unknown. 6 Phase 1, 3 Phase 2, 2 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Recruiting 3 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Not applicable | 2 | Recruiting 2 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Gastrointestinal Tumor: new trials by email Literature Review of Gastrointestinal Tumor trials Research Report on Gastrointestinal Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope Endoscopic ultrasound examination - Pancreatic Disease, Pancreatic Cancer | Not applicable | Recruiting | Orlando Health, Inc. | 140 | 2026-10-01 | 2026-10-20 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors SI-B036 - Gastrointestinal Tumor, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 10 | 2026-07-30 | 2026-09-04 |
| A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors BL-M09D1 - Gastrointestinal Tumor, Solid Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 45 | 2025-05-15 | 2025-05-31 |
| REmote Symptom COllection to improVE postopeRative Care Voice-Assisted Remote Symptom Monitoring System (VARSMS) - Gastrointestinal Cancer, Gastrointestinal Tumor | Not applicable | Recruiting | Medstar Health Research Institute | 281 | 2024-07-23 | 2025-04-03 |
| A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor BL-B01D1 - Gastrointestinal Tumor | Phase 1 | Recruiting | Sichuan Baili Pharmaceutical Co., Ltd. | 96 | 2022-02-14 | 2026-08-27 |
| A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital) Tumor Infiltrating Lymphocytes (TIL) - Gastrointestinal Tumor | Early Phase 1 | Recruiting | Shanghai Juncell Therapeutics | 50 | 2021-06-30 | 2026-08-05 |
| Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany), tislelizumab (BeiGene, China) combined with PD-1 inhibitor - Gastrointestinal Tumor | Phase 1 / Phase 2 | Completed | Pengyuan Liu | 18 | 2020-06-01 | 2023-09-05 |
| Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors Pyrotinib with or without trastuzumab - Gastrointestinal Tumor, Effect of Drug | Phase 2 | Unknown | Fudan University | 60 | 2020-02-01 | 2021-07-14 |
| Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma Cisplatin, Gemcitabine, Copanlisib - Biliary Carcinoma, Gall Bladder Carcinoma | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 24 | 2016-07-05 | 2021-08-04 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas alemtuzumab, fludarabine, sirolimus - Ewing Sarcoma, Gastrointestinal Tumor | Phase 1 | Completed | St. Jude Children's Research Hospital | 23 | 2012-08-20 | 2026-02-06 |
| Phase I Trial of Combination of FOLFIRI and SOM 230 SOM230C LAR, FOLFIRI Infusion - Gastrointestinal Tumor | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 16 | 2011-09-01 | 2015-12-24 |
Digestive System Neoplasms (11) · Gastrointestinal Neoplasms (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Adenocarcinoma, Clear Cell (1) · Bile Duct Diseases (1) · Bile Duct Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Hyperthermia (1) · Lymphoma (1)
Digestive System Diseases (11) · Neoplasms (11) · Neoplasms by Site (11) · Gastrointestinal Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Adenocarcinoma (2) · Biliary Tract Diseases (2) · Biliary Tract Neoplasms (2) · Carcinoma (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Neoplastic Processes (2) · Pathologic Processes (2)
Alemtuzumab (1) · Busulfan (1) · Cisplatin (1) · Fluorouracil (1) · Gemcitabine (1) · Immune Checkpoint Inhibitors (1) · Irinotecan (1) · Leucovorin (1) · Melphalan (1) · Sirolimus (1) · Stem Cell Transplantation (1) · Trastuzumab (1) · copanlisib (1) · fludarabine (1) · pyrotinib (1)
Sichuan Baili Pharmaceutical Co., Ltd. (3) · H. Lee Moffitt Cancer Center and Research Institute (2) · Fudan University (1) · Medstar Health Research Institute (1) · Orlando Health, Inc. (1) · Pengyuan Liu (1) · Shanghai Juncell Therapeutics (1) · St. Jude Children's Research Hospital (1)
China (6) · United States (5)
Brando Triplett, MD (1) · Ji Young Bang, MD MPH (1) · Jun Chen (1) · Lin Shen, PHD (1) · Qing Xu (1) · Richard D. Kim, M.D. (1) · Richard Kim, M.D. (1) · Xiaodong Zhu, phD (1)